This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horwitz, M. S.
Right arrow Articles by Sarvetnick, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horwitz, M. S.
Right arrow Articles by Sarvetnick, N.

 Previous Article  |  Next Article 

Journal of Virology, March 1999, p. 1756-1766, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Protection from Lethal Coxsackievirus-Induced Pancreatitis by Expression of Gamma Interferondagger

Marc S. Horwitz, Troy Krahl, Cody Fine, Jae Lee, and Nora Sarvetnick*

Department of Immunology, The Scripps Research Institute, La Jolla, California 92037

Received 19 October 1998/Accepted 12 November 1998

Coxsackievirus infection causes severe pancreatitis and myocarditis in humans, often leading to death in young or immunocompromised individuals. In susceptible strains of mice, coxsackievirus strain CB4 causes lethal hypoglycemia. To investigate the potential of gamma interferon (IFN-gamma ) in protection and clearance of the viral infection, IFN-gamma knockout mice and transgenic (Tg) mice specifically expressing IFN-gamma in their pancreatic beta  cells were infected with CB4. Lack of IFN-gamma in mice normally resistant to CB4-mediated disease resulted in hypoglycemia and rapid death. However, expression of IFN-gamma in the beta  cells of Tg mice otherwise susceptible to lethal infection allowed for survival and protected them from developing the accompanying hypoglycemia. While all the mice had high levels of viral replication in their pancreata and comparable tissue pathology following viral infection, the Tg mice had significantly lower levels of virus at the peak of infection, significantly higher numbers of activated macrophages before and after infection, and less damage to their acinar tissue. Additionally, despite having increased levels of inducible nitric oxide synthetase (iNOS) expression, treatment of Tg mice with the iNOS inhibitor aminoguanidine did not alter the level of protection afforded by IFN-gamma expression. In conclusion, IFN-gamma protects from lethal coxsackievirus infection by activating macrophages in an iNOS-independent manner.

* Corresponding author. Mailing address: Department of Immunology (IMM-23), The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (619) 784-9066. Fax: (619) 784-9083. E-mail: noras{at}scripps.edu.

dagger This is manuscript number 11674-IMM from The Scripps Research Institute.

Journal of Virology, March 1999, p. 1756-1766, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Negishi, H., Osawa, T., Ogami, K., Ouyang, X., Sakaguchi, S., Koshiba, R., Yanai, H., Seko, Y., Shitara, H., Bishop, K., Yonekawa, H., Tamura, T., Kaisho, T., Taya, C., Taniguchi, T., Honda, K. (2008). A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA 105: 20446-20451 [Abstract] [Full Text]  
  • Moraes, M. P., de los Santos, T., Koster, M., Turecek, T., Wang, H., Andreyev, V. G., Grubman, M. J. (2007). Enhanced Antiviral Activity against Foot-and-Mouth Disease Virus by a Combination of Type I and II Porcine Interferons. J. Virol. 81: 7124-7135 [Abstract] [Full Text]  
  • Fairweather, D., Frisancho-Kiss, S., Yusung, S. A., Barrett, M. A., Davis, S. E., Steele, R. A., Gatewood, S. J. L., Rose, N. R. (2005). IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-{gamma} and Macrophage and Neutrophil Populations in the Heart. J. Immunol. 174: 261-269 [Abstract] [Full Text]  
  • Klingel, K., Schnorr, J.-J., Sauter, M., Szalay, G., Kandolf, R. (2003). {beta}2-Microglobulin-Associated Regulation of Interferon-{gamma} and Virus-Specific Immunoglobulin G Confer Resistance Against the Development of Chronic Coxsackievirus Myocarditis. Am. J. Pathol. 162: 1709-1720 [Abstract] [Full Text]  
  • Zipris, D., Hillebrands, J.-L., Welsh, R. M., Rozing, J., Xie, J. X., Mordes, J. P., Greiner, D. L., Rossini, A. A. (2003). Infections That Induce Autoimmune Diabetes in BBDR Rats Modulate CD4+CD25+ T Cell Populations. J. Immunol. 170: 3592-3602 [Abstract] [Full Text]  
  • Kimura, K., Kakimi, K., Wieland, S., Guidotti, L. G., Chisari, F. V. (2002). Activated Intrahepatic Antigen-Presenting Cells Inhibit Hepatitis B Virus Replication in the Liver of Transgenic Mice. J. Immunol. 169: 5188-5195 [Abstract] [Full Text]  
  • Henke, A., Zell, R., Ehrlich, G., Stelzner, A. (2001). Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis. J. Virol. 75: 8187-8194 [Abstract] [Full Text]  
  • Wessely, R., Klingel, K., Knowlton, K. U., Kandolf, R. (2001). Cardioselective Infection With Coxsackievirus B3 Requires Intact Type I Interferon Signaling : Implications for Mortality and Early Viral Replication. Circulation 103: 756-761 [Abstract] [Full Text]  
  • Zaragoza, C., Ocampo, C. J., Saura, M., Bao, C., Leppo, M., Lafond-Walker, A., Thiemann, D. R., Hruban, R., Lowenstein, C. J. (1999). Inducible Nitric Oxide Synthase Protection Against Coxsackievirus Pancreatitis. J. Immunol. 163: 5497-5504 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»